Effect of resveratrol on non‑alcoholic fatty liver disease
The aim of the present study was to investigate the effect of a micronized formulation of trans‑resveratrol in humans with non‑alcoholic fatty liver disease (NAFLD). Published online on: May 23, 2019 Abstract The aim of the!-->!-->!-->!-->!-->…